LEP and melanoma: Although LEP-based targeting therapies have not yet been fully applied, LEP has already been identified as a potent metabolic reprogramming agent to support antitumor responses in aggressive melanomas (Waldman et al., 2020; de la Cruz-Merino et al., 2019; Rivadeneira et al., 2019).